MPI Research is pleased to announce the addition of Ali Said Faqi, DVM, Ph.D., D.A.B.T to our scientific staff as Director of Developmental and Reproductive Toxicology. Dr. Faqi recently came to MPI Research from Allergan, Inc., where he was responsible for monitoring internal and outsourced toxicology studies, and for the preparation of regulatory documents for submission to worldwide agencies in compliance with ICH, FDA, CPMP and other guidelines. Prior to joining Allergan, Dr. Faqi served as Head of Developmental/Reproductive and Neurotoxicology at IIT Research Institute in Chicago, IL. Dr. Faqi received his DVM from the Somali National University in 1982 and then went on to receive his Diploma of Specialization in Experimental Pharmacology from the University of Milan-Italy in 1986. Dr. Faqi attended the University of Leipzig in Germany where he earned his Doctorate of Developmental and Reproductive Toxicology in 1995, and received his DABT certification in 2002. Dr. Faqi has over 55 publications and abstracts to his credit in the areas of reproductive, developmental toxicology and fertility assessment.

At MPI Research, Dr. Faqi will be responsible for the overall developmental and reproductive toxicology area, including expanding the number of sponsors conducting such studies at MPI Research and working with these sponsors on the design and execution of these studies in accordance with all ICH, OECD and other regulatory guidelines. He will lead an existing team of talented scientists and technical staff in the conduct of these studies and he will be responsible for updating procedures, training, and equipment as both regulations and technologies change.

Dr. David Serota, Director of Toxicology, commented, “We feel extremely fortunate to have Dr. Faqi join our team. His experiences in the academic field as well as in the contract research and pharmaceutical industries have prepared him well for this leadership position at MPI Research. I believe that Dr. Faqi is a stellar individual who lends great credibility of our organization, and I welcome him to our family.”

MPI Research exists to provide comprehensive non-clinical research that meets the requirements of pharmaceutical, medical device, animal health and chemical companies as well as governmental agencies as we partner together to bring safer, healthier products to the world. MPI Research employees specialize in a wide variety of scientific disciplines including toxicology, pharmacology, metabolism, pathology, clinical pathology, reproductive and developmental biology, veterinary science, neuroscience, experimental therapeutics, immunotoxicology, analytical chemistry, computer science, regulatory science, and statistics.

Home | News